PERSPECTIVE THERAPEUTICS, INC. Inventory Write-down
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Inventory Write-down of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2024-11-12
- PERSPECTIVE THERAPEUTICS, INC. inventory write-down for the quarter ending 2024-09-30 was $0.00.
- PERSPECTIVE THERAPEUTICS, INC. inventory write-down for the quarter ending 2023-12-31 was $0.00.
- PERSPECTIVE THERAPEUTICS, INC. inventory write-down for the quarter ending 2023-09-30 was $0.00.
- PERSPECTIVE THERAPEUTICS, INC. inventory write-down for the quarter ending 2022-12-31 was $0.00.
- PERSPECTIVE THERAPEUTICS, INC. inventory write-down for fiscal 2023 was $298.00K.
- PERSPECTIVE THERAPEUTICS, INC. inventory write-down for fiscal 2022 was $0.00.
- PERSPECTIVE THERAPEUTICS, INC. inventory write-down for fiscal 2022 was $0.00.
- PERSPECTIVE THERAPEUTICS, INC. inventory write-down for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 9 month as first filed | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | |||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $298.00K 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $298.00K 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | $298.00K 10-Q · filed 2024-08-13 | |||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-11 | $0.00 10-K · filed 2024-03-28 | ||||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $0.00 10-K · filed 2017-09-28 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | |||||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-26 | $72.00K 10-K · filed 2018-09-26 | $72.20K 10-K · filed 2016-09-09 | |||
| 2016-03-31 | $72.00K 10-Q · filed 2017-05-10 | $72.20K 10-Q · filed 2016-05-10 | ||||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $0.00 10-K · filed 2017-09-28 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | |||||
| 2014-06-30 | $0.00 10-K · filed 2016-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |